FFIV Form 4: Chief People Officer Disposes of 2,701 Shares Under 10b5-1 Plan

Rhea-AI Filing Summary

F5, Inc. (FFIV) Form 4 summary — The reporting person, Schramm Lyra Amber, identified as Chief People Officer, reported a sale of 2,701 shares of F5 common stock on 09/08/2025 at a price of $316.57 per share. The filing states the transaction was executed pursuant to a Rule 10b5-1 trading plan dated 06/09/2025. Following the reported disposition the filing shows 0 shares beneficially owned. The Form 4 was signed by Angelique M. Okeke by power of attorney on 09/09/2025. This disclosure records an officer-initiated sale under a pre-established plan; no additional financial results, forward guidance, or other transactions are included in this filing.

Positive

• None.

Negative

• Reported disposition of 2,701 shares at $316.57 per share on 09/08/2025, leaving 0 shares beneficially owned following the transaction

Insights

Financial Analyst

TL;DR: Officer sale of 2,701 shares executed under a Rule 10b5-1 plan; filing shows no remaining beneficial ownership.

The Form 4 documents a routine, pre-planned disposition by an executive officer rather than an opportunistic open-market trade. The sale size and price are explicitly stated: 2,701 shares at $316.57 each on 09/08/2025. Because the sale was made under a 10b5-1 plan dated 06/09/2025, it meets the filing's stated affirmative-defense conditions. From a numbers perspective, the filing reports 0 shares owned after the transaction. This is a disclosure event rather than an operational or financial development for the company.

Corporate Governance Expert

TL;DR: Disclosure shows compliance with Rule 10b5-1 and timely Form 4 reporting; no governance changes reported.

The document confirms procedural compliance: the transaction is identified as executed pursuant to a Rule 10b5-1 trading plan and was reported on Form 4 with a signature executed by power of attorney. The reporting person is listed as an officer (Chief People Officer). The filing contains no information on leadership changes, board actions, or amendments to executive agreements. As a governance disclosure, it is routine and informational.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHRAMM LYRA AMBER

(Last) (First) (Middle)

C/O F5, INC.

801 5TH AVE.

(Street)

SEATTLE WA 98104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
F5, INC. [ FFIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2025		S		2,701(1)	D	$316.57	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 6/9/2025.

Remarks:

	/s/ Angelique M. Okeke by Power of Attorney	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for F5 (FFIV) disclose on 09/08/2025?

The Form 4 discloses that Chief People Officer Schramm Lyra Amber sold 2,701 shares at $316.57 per share on 09/08/2025 under a Rule 10b5-1 plan.

Was the sale executed under a Rule 10b5-1 trading plan?

Yes. The filing states the transaction was executed pursuant to a Rule 10b5-1 trading plan dated 06/09/2025.

How many shares does the reporting person own after the reported transaction?

The Form 4 reports 0 shares beneficially owned following the reported disposition.

Who signed the Form 4 and when was it filed?

The Form 4 shows a signature by Angelique M. Okeke by power of attorney on 09/09/2025.

Does the filing report any other transactions or derivative holdings?

No. The Form 4 contains only the reported non-derivative disposition of common stock and includes no derivative transactions.